{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:52:31Z","timestamp":1793505151460,"version":"4.5.0"},"reference-count":48,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,1,1]]},"abstract":"\n Objective.<\/jats:title>\n Despite its relative frequency among autosomal recessive diseases and the availability of the sweat test, cystic fibrosis (CF) has been difficult to diagnose in early childhood, and delays can lead to severe malnutrition, lung disease, or even death. The Wisconsin CF Neonatal Screening Project was designed as a randomized clinical trial to assess the benefits and risks of early diagnosis through screening. In addition, the incidence of CF was determined, and the validity of our randomization method assessed by comparing 16 demographic variables.<\/jats:p>\n <\/jats:sec>\n \n Methodology.<\/jats:title>\n Immunoreactive trypsinogen analysis was applied to dried newborn blood specimens for recognition of CF risk from 1985 to 1991 and was coupled to DNA-based detection of the \u0394F508 mutation from 1991 to 1994. Randomization of 650\u2009341 newborns occurred when their blood specimens reached the Wisconsin screening laboratory. This created 2 groups\u2014an early diagnosis, screened cohort and a standard diagnosis or control group. To avoid selection bias, we devised a unique unblinding method with a surveillance program to completely identify the control subjects. Because sequential analysis of nutritional outcome measures revealed significantly better growth in screened patients during 1996, we accelerated the unblinding and completely identified the control group by April 1998. Having each member of this cohort enrolled and evaluated for at least 1 year and having completed a comprehensive surveillance program, we performed another statistical analysis of anthropometric evaluated indices that includes all CF patients without meconium ileus.<\/jats:p>\n <\/jats:sec>\n \n Results.<\/jats:title>\n The incidence of classical CF, ie, patients diagnosed in this trial with a sweat chloride of 60 mEq\/L greater, was 1:4189. By incorporating other CF patients born during the randomization period, including 2 autopsy diagnosed patients and 8 probable patients, we calculate a maximum incidence of 1:3938 (95% confidence interval: 3402\u20134611). Although there were group differences in the proportion of patients with \u0394F508 genotypes and with pancreatic insufficiency, validity of the randomization plan was demonstrated by analyzing 16 demographic variables and finding no significant difference after adjustment for multiple comparisons. Focusing on patients without meconium ileus, we found a marked difference in the mean \u00b1 standard deviation age of diagnosis for screened patients (13 \u00b1 37 weeks), compared with the standard diagnosis group (100 \u00b1 117). Anthropometric indices of nutritional status were significantly higher at diagnosis in the screened group, including length\/height, weight, and head circumference. During 13 years of study, despite similar nutritional therapy and the inherently better pancreatic status of the control group, analysis of nutritional outcomes revealed significantly greater growth associated with early diagnosis. Most impressively, the screened group had a much lower proportion of patients with weight and height data below the 10th percentile throughout childhood.<\/jats:p>\n <\/jats:sec>\n \n Conclusions.<\/jats:title>\n Although the screened group had a higher proportion of patients with pancreatic insufficiency, their growth indices were significantly better than those of the control group during the 13-year follow-up evaluation and, therefore, this randomized clinical trial of early CF diagnosis must be interpreted as unequivocally positive. Our conclusions did not change when the height and weight data before 4 years of age for the controls detected by unblinding were included in the analysis. Also, comparison of growth outcomes after 4 years of age in all subjects showed persistence of the significant differences. Therefore, selection bias has been eliminated as a potential explanation. In addition, the results show that severe malnutrition persists after delayed diagnosis of CF and that catch-up may not be possible. We conclude that early diagnosis of CF through neonatal screening combined with aggressive nutritional therapy can result in significantly enhanced long-term nutritional status.<\/jats:p>\n <\/jats:sec>","DOI":"10.1542\/peds.107.1.1","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T19:55:51Z","timestamp":1092426951000},"page":"1-13","source":"Crossref","is-referenced-by-count":468,"title":["Early Diagnosis of Cystic Fibrosis Through Neonatal Screening Prevents Severe Malnutrition and Improves Long-Term Growth"],"prefix":"10.1542","volume":"107","author":[{"given":"Philip M.","family":"Farrell","sequence":"first","affiliation":[{"name":"From the University of Wisconsin Medical School, Madison, Wisconsin;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Kosorok","sequence":"additional","affiliation":[{"name":"From the University of Wisconsin Medical School, Madison, Wisconsin;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Rock","sequence":"additional","affiliation":[{"name":"From the University of Wisconsin Medical School, Madison, Wisconsin;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Laxova","sequence":"additional","affiliation":[{"name":"From the University of Wisconsin Medical School, Madison, Wisconsin;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zeng","sequence":"additional","affiliation":[{"name":"From the University of Wisconsin Medical School, Madison, Wisconsin;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Chuan","family":"Lai","sequence":"additional","affiliation":[{"name":"From the University of Wisconsin Medical School, Madison, Wisconsin;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Hoffman","sequence":"additional","affiliation":[{"name":"State Laboratory of Hygiene, Madison, Wisconsin; and the"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald H.","family":"Laessig","sequence":"additional","affiliation":[{"name":"State Laboratory of Hygiene, Madison, Wisconsin; and the"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Splaingard","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin, Milwaukee, Wisconsin."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Wisconsin Cystic Fibrosis Neonatal Screening Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2001,1,1]]},"reference":[{"key":"2021121009592966100_B1"},{"key":"2021121009592966100_B2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0065-3101(24)00279-2","article-title":"Newborn screening for cystic fibrosis.","volume":"39","author":"Farrell","year":"1992","journal-title":"Adv Pediatr"},{"key":"2021121009592966100_B3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0065-3101(23)00095-6","article-title":"Improving the health of patients with cystic fibrosis through newborn screening.","volume":"47","author":"Farrell","year":"2000","journal-title":"Adv Pediatr."},{"key":"2021121009592966100_B4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/adc.66.1_Spec_No.29","article-title":"Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening.","volume":"66","author":"Chatfield","year":"1991","journal-title":"Arch Dis Child"},{"key":"2021121009592966100_B5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/adc.77.6.493","article-title":"Incidence, population, and survival of cystic fibrosis in the UK, 1968\u20131995.","volume":"77","author":"Dodge","year":"1997","journal-title":"Arch Dis Child"},{"key":"2021121009592966100_B6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0022-3476(98)70024-1","article-title":"Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition.","volume":"132","author":"Lai","year":"1998","journal-title":"J Pediatr"},{"key":"2021121009592966100_B7","first-page":"113","article-title":"Cystic fibrosis: diagnostic considerations.","volume":"150","author":"Rosenstein","year":"1982","journal-title":"Johns Hopkins Med J"},{"key":"2021121009592966100_B8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0009-9120(84)90541-1","article-title":"Advances in the diagnosis and management of cystic fibrosis.","volume":"17","author":"Blythe","year":"1984","journal-title":"Clin Biochem"},{"key":"2021121009592966100_B9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/ajmg.1320450613","article-title":"Progressive malnutrition, severe anemia, hepatic dysfunction, and respiratory failure in a three-month-old white girl.","volume":"45","author":"Farrell","year":"1993","journal-title":"Am J Med Genet"},{"key":"2021121009592966100_B10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/000992289403300101","article-title":"Severe hemolytic anemia associated with vitamin E deficiency in infants with cystic fibrosis.","volume":"33","author":"Wilfond","year":"1994","journal-title":"Clin Pediatr"},{"key":"2021121009592966100_B11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1651-2227.1978.tb16273.x","article-title":"Relative underweight in cystic fibrosis and its prognostic value.","volume":"67","author":"Kraemer","year":"1978","journal-title":"Acta Paediatr Scand"},{"key":"2021121009592966100_B12","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0140-6736(79)90825-0","article-title":"Dried-blood spot screening for cystic fibrosis in the newborn.","volume":"1","author":"Crossley","year":"1979","journal-title":"Lancet"},{"key":"2021121009592966100_B13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0925-6164(93)90017-D","article-title":"Newborn screening for cystic fibrosis: its evolution and a review of the current situation.","volume":"2","author":"Wilcken","year":"1993","journal-title":"Screening"},{"key":"2021121009592966100_B14","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM199109123251104","article-title":"Efficacy of state-wide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations.","volume":"325","author":"Hammond","year":"1991","journal-title":"N Engl J Med"},{"key":"2021121009592966100_B15","first-page":"616","article-title":"Application of DNA analysis in a population-screening program for neonatal diagnosis of cystic fibrosis (CF): comparison of screening protocols.","volume":"52","author":"Gregg","year":"1993","journal-title":"Am J Hum Genet"},{"key":"2021121009592966100_B16","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1542\/peds.99.6.819","article-title":"Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods.","volume":"99","author":"Gregg","year":"1997","journal-title":"Pediatrics"},{"key":"2021121009592966100_B17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0022-3476(95)70040-4","article-title":"Neonatal screening for cystic fibrosis: a comparison of two strategies for case detection in 1.2 million babies.","volume":"127","author":"Wilcken","year":"1995","journal-title":"J Pediatr"},{"key":"2021121009592966100_B18","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1542\/peds.72.5.741","article-title":"Neonatal screening for cystic fibrosis: position paper.","volume":"72","author":"Cystic Fibrosis Foundation, Ad Hoc Committee Task Force on Neonatal Screening","year":"1983","journal-title":"Pediatrics"},{"key":"2021121009592966100_B19","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1056\/NEJM199710023371403","article-title":"Nutritional benefits of neonatal screening for cystic fibrosis.","volume":"337","author":"Farrell","year":"1997","journal-title":"N Engl J Med"},{"key":"2021121009592966100_B20","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/bmj.316.7129.404","article-title":"Neonatal screening for cystic fibrosis.","volume":"316","author":"Wald","year":"1998","journal-title":"Br Med J"},{"key":"2021121009592966100_B21"},{"key":"2021121009592966100_B22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ppul.1950110704","article-title":"Current issues in neonatal screening for cystic fibrosis and implications of the CF gene discovery.","volume":"7","author":"Farrell","year":"1991","journal-title":"Pediatr Pulmonol Suppl"},{"key":"2021121009592966100_B23","first-page":"524","article-title":"Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis.","volume":"97","author":"Farrell","year":"1996","journal-title":"Pediatrics"},{"key":"2021121009592966100_B24","first-page":"833","article-title":"State of the art: cystic fibrosis.","volume":"113","author":"Wood","year":"1976","journal-title":"Am Rev Respir Dis"},{"key":"2021121009592966100_B25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/(SICI)1097-0258(19960315)15:5<449::AID-SIM173>3.0.CO;2-X","article-title":"The incidence of cystic fibrosis.","volume":"15","author":"Kosorok","year":"1996","journal-title":"Stat Med"},{"key":"2021121009592966100_B26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1542\/peds.105.1.53","article-title":"Nutritional status of patients with cystic fibrosis with meconium ileus: a comparison with patients without meconium ileus and diagnosed early through neonatal screening.","volume":"105","author":"Lai","year":"2000","journal-title":"Pediatrics"},{"key":"2021121009592966100_B27"},{"key":"2021121009592966100_B28"},{"key":"2021121009592966100_B29","first-page":"495","article-title":"A prospective randomized trial of early diagnosis and treatment of cystic fibrosis: a unique ethical dilemma.","volume":"37","author":"Fost","year":"1989","journal-title":"Clin Res"},{"key":"2021121009592966100_B30","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/ajcn\/54.3.578","article-title":"Nutritional status of infants with cystic fibrosis as related to dietary intake.","volume":"54","author":"Marcus","year":"1991","journal-title":"Am J Clin Nutr"},{"key":"2021121009592966100_B31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/ajcn\/55.1.108","article-title":"Nutritional assessment and management of cystic fibrosis: a consensus report.","volume":"55","author":"Ramsey","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"2021121009592966100_B32"},{"key":"2021121009592966100_B33","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0002-8223(21)03321-6","article-title":"Predigested formula for infants with cystic fibrosis.","volume":"87","author":"Farrell","year":"1987","journal-title":"J Am Diet Assoc"},{"key":"2021121009592966100_B34","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/ajcn\/63.5.746","article-title":"Effect of linoleic acid intake on growth of infants with cystic fibrosis.","volume":"63","author":"van Egmond","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"2021121009592966100_B35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-2007-1011506","article-title":"Treatment of pulmonary disease in cystic fibrosis.","volume":"6","author":"Mischler","year":"1985","journal-title":"Semin Respir Med"},{"key":"2021121009592966100_B36"},{"key":"2021121009592966100_B37"},{"key":"2021121009592966100_B38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models.","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"2021121009592966100_B39","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJM199204303261804","article-title":"Prediction of mortality in patients with cystic fibrosis.","volume":"326","author":"Kerem","year":"1992","journal-title":"N Engl J Med"},{"key":"2021121009592966100_B40","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM199011293232203","article-title":"The relation between genotype and phenotype in cystic fibrosis-analysis of the most common mutation (\u0394F508).","volume":"323","author":"Kerem","year":"1990","journal-title":"N Engl J Med"},{"key":"2021121009592966100_B41","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/ajcn\/32.3.607","article-title":"Physical growth: National Center for Health Statistics percentiles.","volume":"32","author":"Hamill","year":"1979","journal-title":"Am J Clin Nutr"},{"key":"2021121009592966100_B42","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1136\/fn.80.1.F1","article-title":"Clinical outcomes of newborn screening for cystic fibrosis.","volume":"80","author":"Waters","year":"1999","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2021121009592966100_B43","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/thx.50.7.712","article-title":"Long term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening in a cystic fibrosis centre.","volume":"50","author":"Dankert-Roelse","year":"1995","journal-title":"Thorax"},{"key":"2021121009592966100_B44","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1001\/archpedi.1958.02060060008002","article-title":"Long-term study of one hundred five patients with cystic fibrosis: studies made over a five- to fourteen-year period.","volume":"96","author":"Schwachman","year":"1958","journal-title":"Am J Dis Child"},{"key":"2021121009592966100_B45","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/adc.72.2.150","article-title":"Disproportionate head growth retardation in cystic fibrosis.","volume":"72","author":"Ghosal","year":"1995","journal-title":"Arch Dis Child"},{"key":"2021121009592966100_B46"},{"key":"2021121009592966100_B47","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1001\/jama.1984.03340360046028","article-title":"Assessing the effectiveness of community screening programs.","volume":"251","author":"Cadman","year":"1984","journal-title":"JAMA"},{"key":"2021121009592966100_B48"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/107\/1\/1\/888472\/1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/107\/1\/1\/888472\/1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T02:54:40Z","timestamp":1734490480000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/107\/1\/1\/66533\/Early-Diagnosis-of-Cystic-Fibrosis-Through"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1,1]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2001,1,1]]},"published-print":{"date-parts":[[2001,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.107.1.1","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[2001,1,1]]}}}